Scientists from Meassage University on the eve of the informed public: science is on the verge of opening a new means to prevent heart attacks and reduce the degree of damage in myocardial infarction. In the study, researchers examined the adenosine A1 receptor. This receptor belongs to the group of G-proteins. But the basis of the obtained data, the researchers developed a theory of a new class of drugs for the heart.
The GPCR receptors are involved in the vast majority of pathological and physiological processes of the human body, including heart attacks, diabetes, weight gain, inflammation, Oncology. Most medicines perform their function through effects on certain groups of receptors. It is so therapeutic effect, for example, analgesics.
The receptor is the basic lever of influence on a living organism. The receptor of individual organs will allow you to create the perfect drug, acting solely on the hearth. It should be noted that while researchers are far from run of similar resources on the pharmaceutical market. The main problems arise in the selection dosages receptor A1. Overdose threatens to stop the heart, and the minimum dose not have a therapeutic effect.